Immunotherapy- (Blinatumomab-) Related Lineage Switch of KMT2A/AFF1 Rearranged B-Lymphoblastic Leukemia into Acute Myeloid Leukemia/Myeloid Sarcoma and Subsequently into B/Myeloid Mixed Phenotype Acute Leukemia

The presence of KMT2A/AFF1 rearrangement in B-lymphoblastic leukemia (B-ALL) is an independent poor prognostic factor and has been associated with higher rate of treatment failure and higher risk of linage switch under therapy. Blinatumomab has shown promising therapeutic results in refractory or re...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Case Rep Hematol
Hlavní autoři: He, Rui R., Nayer, Zacharia, Hogan, Matthew, Cuevo, Raymund S., Woodward, Kimberly, Heyer, David, Curtis, Christine A., Peterson, Jess F.
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2019
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6925828/
https://ncbi.nlm.nih.gov/pubmed/31885955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7394619
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky